BHIC (BioScience Health Innovations) Beta: 2.3987 (As of Jun. 26, 2026)


BHIC BioScience Health Innovations Inc BHIC
45 GF Score
Price $4.35
GF Value $164.84
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is BioScience Health Innovations Beta?

BioScience Health Innovations BHIC 45 Beta is 2.3987 as of Jun. 26, 2026. GuruFocus rates BHIC with a GF Score™ of 45/100 and a GF Value™ of $164.84 (Possible Value Trap). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), BioScience Health Innovations's Beta is 2.3987.


BioScience Health Innovations  (OTCPK:BHIC) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


BioScience Health Innovations Beta Related Terms


BioScience Health Innovations Beta Historical Data

* Premium members only.

The historical data trend for BioScience Health Innovations's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioScience Health Innovations Beta Chart

BioScience Health Innovations Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 -0.68 0.11

BioScience Health Innovations Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.69 -1.02 0.02 0.11 0.75

BHIC vs PETS, SHFH, SCNX: Beta Comparison

For the Pharmaceutical Retailers subindustry, BioScience Health Innovations's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioScience Health Innovations Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioScience Health Innovations's Beta distribution charts can be found below:

* The bar in red indicates where BioScience Health Innovations's Beta falls into.


BHIC
45GF Score
BioScience Health Innovations Inc BHIC
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioScience Health Innovations Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.3987 mean?
BioScience Health Innovations (BHIC) has a Beta of 2.3987 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for BioScience Health Innovations and its competitors.
Is BioScience Health Innovations' Beta too high?
BioScience Health Innovations' current Beta is 2.3987. Overall, BioScience Health Innovations has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioScience Health Innovations' Beta compare to PETS and SHFH?
BioScience Health Innovations' Beta of 2.3987 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for BioScience Health Innovations and its competitors. BioScience Health Innovations's current Beta is 2.3987. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioScience Health Innovations stock overvalued right now?
Based on GuruFocus' analysis, BioScience Health Innovations (BHIC) is currently considered Possible Value Trap. The stock's GF Value™ is $164.84, compared to a current price of $4.35 — trading 97.4% below its estimated fair value. The current Beta is 2.3987. BioScience Health Innovations' overall GF Score™ is 45/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For BioScience Health Innovations (BHIC), the current Beta is 2.3987 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioScience Health Innovations (BHIC) Overvalued in 2026?

Based on GuruFocus' analysis, BioScience Health Innovations stock appears to be undervalued. The current stock price of $4.35 is trading 97.4% below its estimated GF Value™ of $164.84. GuruFocus considers BioScience Health Innovations to be Possible Value Trap.

Key valuation signals for BHIC:

  • Beta: 2.3987
  • GF Value™: $164.84 vs. price of $4.35 (97.4% below fair value)
  • GF Score™: 45/100 with 5 warning signs

No single metric tells the full story. See the BHIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioScience Health Innovations Business Description

Address 14857 South Concord Park Drive, Bluffdale, UT, USA, 84065
BioScience Health Innovations Inc is engaged in full-scale operations as a distributor and generates revenue. The company's main business is to sell clinically tested, affordably priced products to naturally battle the onslaught of bacteria and viruses through online sales and various other distribution channels. The company develops, manufactures, and distributes science-backed nutritional supplements and delivery systems targeting cellular health, mitochondrial optimization, hormonal balance, and longevity.
45GF Score

Get the complete analysis for BHIC

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.35
Price
$164.84
GF Value